← Evidence map

ReviewPeerJ2026

From mechanism to therapeutics: targeting the mitogen-activated protein kinase 1 (MAPK1)/extracellular signal-regulated kinase 2 (ERK2) pathway in renal fibrosis.

Monan Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

From mechanism to therapeutics: targeting the mitogen-activated protein kinase 1 (MAPK1)/extracellular signal-regulated kinase 2 (ERK2) pathway in renal fibrosis. | Socratic